Who Owns Tenax Therapeutics Stock?
NASDAQ: TENXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 108.50%
- Institutions (% of float)
- 108.69%
- Held by insiders
- 0.18%
- Institutional holders
- 153
- Institutions 99.8%
- Insiders 0.2%
- Public and other 0.0%
Who owns Tenax Therapeutics stock?
Institutional investors own about 108.5% of Tenax Therapeutics's shares, spread across 153 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.18% of TENX.
The largest institutional holders are FMR, LLC (10.53%), Vivo Capital, LLC (6.68%) and Blackrock Inc. (4.62%). Together, the top 10 institutions control 39.7% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their TENX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TENX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 3.94M | 10.53% | +1122.1% |
| Vivo Capital, LLC | 2.50M | 6.68% | +1100.0% |
| Blackrock Inc. | 1.73M | 4.62% | +10078.4% |
| Perceptive Advisors Llc | 1.70M | 4.54% | +17.4% |
| Vanguard Capital Management LLC | 1.15M | 3.07% | +335.5% |
| Millennium Management Llc | 876.23K | 2.34% | +64.1% |
| Ikarian Capital, LLC | 787.60K | 2.10% | -22.6% |
| Candriam S.C.A. | 749.59K | 2.00% | +100.0% |
| Citadel Advisors Llc | 728.56K | 1.95% | +377.7% |
| RTW Investments LP | 696.57K | 1.86% | +88.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TENX
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 969.20K | 2.59% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 852.26K | 2.28% |
| iShares Trust-iShares Russell 2000 ETF | 644.71K | 1.72% |
| T. Rowe Price Health Sciences Fund, Inc. | 445.98K | 1.19% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 445.10K | 1.19% |
| TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund | 432.20K | 1.15% |
| Fidelity Concord Street Trust-Fidelity Small Cap Discovery Fund | 335.02K | 0.90% |
| Fidelity Concord Street Trust-Fidelity Series Small Cap Discovery Fund | 299.10K | 0.80% |
| Fidelity Concord Street Trust-Fidelity Series Small Cap Core Fund | 282.40K | 0.75% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 277.85K | 0.74% |
Frequently asked questions
Who is the largest shareholder of Tenax Therapeutics?
FMR, LLC is the largest institutional shareholder of TENX, owning 10.53% of shares outstanding (3.94M shares) as of its latest 13F filing.
What percentage of Tenax Therapeutics is owned by institutions?
Institutions own about 108.5% of TENX shares and 108.7% of the public float.
How much of Tenax Therapeutics do insiders own?
Insiders, such as officers and directors, own about 0.18% of TENX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.